Improving access to care and services
We collaborate with public and private sector organizations to expand access to care and services to improve global health.
Featured stories
-
-
Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
-
-
Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.
More from Johnson & Johnson
-
What is wAIHA?
Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and Johnson & Johnson’s clinical research and ongoing commitment to patients. -
Behind the relentless pursuit of multiple myeloma cures
For 25 years, Johnson & Johnson has pursued innovative blood cancer treatments. Scientist Kodandaram “Ram” Pillarisetti has helped shape that pursuit, from discovering a target that led to an approved bispecific therapy to research exploring a next-generation trispecific antibody approach. -
The Johnson & Johnson Institute helps HCPs learn new surgery skills—here’s how
From suturing to robotics system training, the Johnson & Johnson Institute is bringing surgical education to busy HCPs so they can deliver safe, effective care.
